口蹄疫病毒O型中和抗体检测固相阻断ELISA方法的建立
作者:
基金项目:

国家重点研发计划(2021YFD1800300)


Development of a solid-phase blocking ELISA for the detection of neutralizing antibodies against foot-and-mouth disease virus serotype O
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [33]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    【目的】为评价O型口蹄疫病毒(foot-and-mouth disease virus,FMDV)灭活疫苗免疫后中和抗体(neutralizing antibodies,NA)水平,建立检测中和抗体的固相阻断ELISA (neutralizing antibodies solid-phase blocking ELISA,NA-SPBE)方法。【方法】本研究以本实验室前期制备的FMDV广谱反应性牛源单克隆抗体E32作为捕获抗体,以生物素标记的FMDV O型型内广谱中和牛源单克隆抗体C4作为检测抗体,经过条件优化建立了检测FMDV O型中和抗体的固相阻断ELISA方法,并对该方法进行了敏感性、特异性、重复性、交叉反应性与病毒中和试验(virus neutralization test,VNT)相关性等试验。【结果】抗体E32最佳包被浓度为0.5 μg/mL,O型FMDV灭活抗原最佳稀释浓度为0.25μg/mL,生物素标记抗体C4-Bio最佳工作浓度为0.06 μg/mL,链霉亲和素-HRP的最佳稀释度为1:40 000。以1.35 log10作为效价判定临界值时,敏感性和特异性分别为97.14%和98.84%。利用该方法分别检测FMDV A型、FMDV Asia1型、BVDV、PRRSV、CSFV、PPRV抗体阳性血清时,均为阴性,未出现交叉反应。该方法批内和批间重复试验的变异系数均<10%,表明其重复性较好。利用该方法与VNT分别对160份血清样品进行检测,二者的相关系数r为0.807 5,P<0.000 1,相关性显著。【结论】该方法可以检测FMDV O型中和抗体,为FMDV O型灭活疫苗免疫效果评价提供有力技术支撑。

    Abstract:

    [Objective] To evaluate the level of neutralizing antibodies (NA) against foot-and-mouth disease virus (FMDV), a solid-phase blocking enzyme-linked immunosorbent assay (ELISA) based on bovine monoclonal antibodies was developed. [Methods] In this study, the bovine monoclonal antibody (mAb) E32 was used as the capture antibody and a biotinylated bovine mAb C4 as the detection antibody. Both mAbs had been produced in our laboratory. The mAb E32 is a cross-reactive antibody against FMDV and the mAb C4 is an intraserotype broadly neutralizing antibody against FMDV serotype O. With the two mAbs, a solid-phase blocking ELISA for detecting neutralizing antibody (NA-SPBE) against FMDV serotype O was developed. The sensitivity, specificity, repeatability, cross-reactivity, and correlation with virus neutralization test (VNT) of this assay were assessed. [Results] The optimum working concentrations of antibody E32, FMDV-inactivated antigen, and biotinylated C4 were 0.5 μg/mL, 0.25 μg/mL and 0.06 μg/mL, respectively, and the optimum dilution of streptavidin-HRP was 1:40 000. When 1.35 log10 was used as the cut-off value, the sensitivity and specificity of the assay were determined as 97.14% and 98.84%, respectively. There was no cross reactivity with the antibodies specific to bovine viral diarrhea virus (BVDV), porcine reproductive and respiratory syndrome virus (PRRSV), classical swine fever virus (CSFV), peste des petits ruminant virus (PPRV), or FMDV serotypes A and Asia1. The intra-batch and inter-batch repeatability of the assay showed the coefficient of variation less than 10%. The detection of 160 serum samples demonstrated a correlation (r=0.807 5, P<0.000 1) between the titers obtained by NA-SPBE and VNT. [Conclusion] NA-SPBE can detect the neutralizing antibodies against FMDV serotype O and provides powerful technical support for evaluating the efficacy of FMDV serotype O-inactivated vaccine.

    参考文献
    [1] Grubman MJ, Baxt B. Foot-and-mouth disease. Clinical Microbiology Reviews, 2004, 17: 465–493.
    [2] Knight-Jones TJ, Rushton J. The economic impacts of foot and mouth disease—what are they how big are they and where do they occur? Preventive Veterinary Medicine, 2013, 112: 161–173.
    [3] Brito BP, Rodriguez LL, Hammond JM, Pinto J, Perez AM. Review of the global distribution of foot-and-mouth disease virus from 2007 to 2014. Transboundary and Emerging Diseases, 2017, 64(2): 316-332.
    [4] 刘在新. 全球口蹄疫防控技术及病原特性研究概观. 中国农业科学, 2015, 48(17): 3547-3564. Liu ZX. Progress and prospect of the technologies to control foot-and-mouth disease and its pathogen characteristics worldwide. Scientia Agricultura Sinica, 2015, 48(17): 3547-3564. (in Chinese)
    [5] 刘俊林, 祁淑芸, 马军武, 崔燕. 液相阻断ELISA在口蹄疫病毒抗体水平检测中的应用. 甘肃农业大学学报, 2008, 43(3): 18-20. Liu JL, Qi SY, Ma JW, Cui Y. Application of liquid-phase blocking ELISA in the detection of antibody levels against foot-and-mouth disease virus. Journal of Gansu Agricultural University, 2008, 43(3): 18-20. (in Chinese)
    [6] Mackay DK, Bulut AN, Rendle T, Davidson F, Ferris NP. A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. Journal of Virological Methods, 2001, 97(1/2): 33-48.
    [7] Aggarwal N, Barnett PV. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species. The Journal of General Virology, 2002, 83(pt 4): 775-782.
    [8] 肖啸, 杨继生, 张静, 程纬. 口蹄疫诊断技术的研究进展. 中国畜牧兽医, 2008, 35(2): 78-81. Xiao X, Yang JS, Zhang J, Cheng W. Foot-and-mouth disease diagnostic technology research progress. China Animal Husbandry Veterinary Medicine, 2008, 35(2): 78-81. (in Chinese)
    [9] Haas B. Application of the FMD liquid-phase blocking sandwich ELISA. Problems encountered in import/export serology and possible solutions. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Vienna, Austria, 1994: 124-127.
    [10] Cao Y, Li K, Wang S, Fu Y, Sun P, Li P, Bai X, Zhang J, Ma X, Xing X, Zhou S, Bao H, Li D, Chen Y, Li Z, Lu Z, Liu Z. Implication of broadly neutralizing bovine monoclonal antibodies in the development of an enzyme-linked immunosorbent assay for detecting neutralizing antibodies against foot-and-mouth disease virus serotype O. Journal of Clinical Microbiology, 2019, 57(12): e01030-19.
    [11] Paiba GA, Anderson J, Paton DJ, Soldan AW, Alexandersen S, Corteyn M, Wilsden G, Hamblin P, MacKay DK, Donaldson AI. Validation of a foot-and-mouth disease antibody screening solid-phase competition ELISA (SPCE). Journal of Virological Methods, 2004, 115(2): 145-158.
    [12] Sevik M, Ozturk FF. Comparative evaluation of liquid-phase blocking ELISA and solid-phase competition ELISA methods for the detection of antibodies to the structural proteins of foot-and-mouth disease types O and A viruses. Turkish Journal of Veterinary and Animal Sciences, 2013, 37: 523-528.
    [13] Li K, He Y, Wang L, Li P, Wang S, Sun P, Bao H, Cao Y, Liu X, Zhu G, Song Y, Bai X, Ma X, Fu Y, Yuan H, Zhang J, Wang J, Chen Y, Li D, Lou Z, Liu Z, Lu Z. Two cross-protective antigen sites on foot-and-mouth disease virus serotype O structurally revealed by broadly neutralizing antibodies from cattle. Journal of Virology, 2021, 95(21): e0088121.
    [14] Chuck AS, Palsson BO. Population balance between producing and nonproducing hybridoma clones is very sensitive to serum level, state of inoculum, and medium composition. Biotechnology and Bioengineering, 1992, 39(3): 354-360.
    [15] Couture ML, Heath CA. Relationship between loss of heavy chains and the appearance of nonproducing hybridomas. Biotechnology and Bioengineering, 1995, 47(2): 270-275.
    [16] Merritt SE, Palsson BO. Loss of antibody productivity is highly reproducible in multiple hybridoma subclones. Biotechnology and Bioengineering, 1993, 42(2): 247-250.
    [17] Ferris NP, Nordengrahn A, Hutchings GH, Reid SM, King DP, Ebert K, Paton DJ, Kristersson T, Brocchi E, Grazioli S, Merza M. Development and laboratory validation of a lateral flow device for the detection of foot-and-mouth disease virus in clinical samples. Journal of Virological Methods, 2009, 155(1): 10-17.
    [18] Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. eLife, 2008, 329(1/2): 112-124.
    [19] Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, Ott RG, Anthony RM, Zebroski H, Hurley A, Phogat A, Chakrabarti B, Li Y, Connors M, Pereyra F, Walker BD, Wardemann H, Ho D, Wyatt RT, Mascola JR, Ravetch JV, Nussenzweig MC. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature, 2009, 458(7238): 636-640.
    [20] Scheid JF, Mouquet H, Feldhahn N, Walker BD, Pereyra F, Cutrell E, Seaman MS, Mascola JR, Wyatt RT, Wardemann H, Nussenzweig MC. A method for identification of HIV gp140 binding memory B cells in human blood. Journal of Immunological Methods, 2009, 343(2): 65-67.
    [21] Pan X. Single cell analysis: from technology to biology and medicine. Single Cell Biology, 2014, 3(1): 106.
    [22] Li K, Wang S, Cao Y, Bao H, Li P, Sun P, Bai X, Fu Y, Ma X, Zhang J, Li D, Chen Y, Liu X, An F, Wu F, Lu Z, Liu Z. Development of foot-and-mouth disease virus-neutralizing monoclonal antibodies derived from plasmablasts of infected cattle and their germline gene usage. Frontiers in Immunology, 2019, 10: 2870.
    [23] 中华人民共和国国家质量监督检验检疫总局. SN/T 1181.2-2003. 口蹄疫病毒抗体检测方法微量血清中和试验. 北京: 中国标准出版社, 2003.
    [24] Mahapatra M, Parida S. Foot and mouth disease vaccine strain selection: current approaches and future perspectives. Expert Review of Vaccines, 2018, 17(7): 577-591.
    [25] 王省. 利用单个B细胞抗体技术研制口蹄疫病毒O型全牛源单克隆工程抗体. 中国农业科学院硕士学位论文, 2019.
    [26] De Los Santos T, Diaz-San Segundo F, Rodriguez LL. The need for improved vaccines against foot-and-mouth disease. Current Opinion in Virology, 2018, 29: 16-25.
    [27] Mahapatra M, Yuvaraj S, Madhanmohan M, Subramaniam S, Pattnaik B, Paton DJ, Srinivasan VA, Parida S. Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses. Vaccine, 2015, 33: 693–700.
    [28] 刘湘涛, 张强, 郭建宏. 口蹄疫. 北京: 中国农业出版社, 2015.
    [29] Pay TW, Hingley PJ. The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle. PLoS One, 1986, 64: 153-161.
    [30] Ahl R, Haas B, Lorenz RJ, Wittman G. Alternative potency test of FMD vaccines and results of comparative antibody assays in different cell systems and ELISA. Report of the meeting of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, FAO, Rome, Italy, 1990: 51–60.
    [31] Pay TW, Hingley PJ. Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge. Protoplasma, 1992, 10(10): 699-706.
    [32] Pantarotto D, Partidos CD, Hoebeke J, Brown F, Kramer E, Briand JP, Muller S, Prato M, Bianco A. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chemistry & Biology, 2003, 10(10): 961-966.
    [33] Kennedy-Stoskopf S, Narayan O. Neutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistence. Environmental Health, 1986, 59(1): 37-44.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

邢向川,李坤,付元芳,包慧芳,李冬,卢曾军,刘在新,曹轶梅. 口蹄疫病毒O型中和抗体检测固相阻断ELISA方法的建立[J]. 微生物学报, 2022, 62(11): 4517-4528

复制
分享
文章指标
  • 点击次数:290
  • 下载次数: 1060
  • HTML阅读次数: 1366
  • 引用次数: 0
历史
  • 收稿日期:2022-03-19
  • 最后修改日期:2022-05-18
  • 在线发布日期: 2022-11-11
  • 出版日期: 2022-11-04
文章二维码